• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, March 12

Ranbaxy Laboratories Ltd announced on Monday that Dr Himadri Sen would be joining the company as President - R&D (Generics & NDDS). Dr Sen, who has a Masters in Pharmacy from the University of Manchester, UK, and a PhD. from Bundelkhand University, Jhansi, has been associated in various capacities with organisations such as Manchester Area Health Authority, UK; St. Mary's Hospital and International Development Laboratories, UK; Imperial Chemical Industries, UK; E.R. Squibb and Sons Ltd, UK; Lupin and Ranbaxy Labs, India.

In a release Mr Malvinder Singh, CEO and Managing Direcotr, Ranbaxy said, "We are very pleased to renew our close association with Dr Sen. His appointment adds significant weight to the substantial research and development effort currently under way at Ranbaxy, while underscoring our commitment to this strategic function that is core to India's future success in the global pharmaceutical industry."

More Stories on : People | Pharmaceuticals | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Minor fire at Vizag Steel Plant

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line